Ledger.Open graph →
SEC Form D · Amendment · filed December 11, 2023

Melt Pharmaceuticals, Inc

Offering
$30.0M
Sold
$20.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BRENTWOOD, TN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Larry Dillaha · Brentwood, TNExecBrad Osborne · Brentwood, TNExecBrad Osborne · Brentwood, TNExecLarry Dillaha · Brentwood, TNExecStephen Czech · New York, NYExecJustin Stach · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗